| Disease | hemophagocytic lymphohistiocytosis |
| Comorbidity | C0023290|visceral leishmaniasis |
| Sentences | 8 |
| PubMedID- 25768375 | Tocilizumab as an adjuvant therapy for hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. |
| PubMedID- 23324220 | hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis in late adulthood. |
| PubMedID- 23511497 | hemophagocytic lymphohistiocytosis (hlh) associated with visceral leishmaniasis (vl) is a very rare phenomenon. |
| PubMedID- 24076317 | [infantile visceral leishmaniasis, an etiology of easily curable hemophagocytic lymphohistiocytosis syndrome]. |
| PubMedID- 23815374 | visceral leishmaniasis with haemophagocytic lymphohistiocytosis: the importance of scrutinising your samples. |
| PubMedID- 20880678 | [treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis]. |
| PubMedID- 22080147 | hemophagocytic syndrome associated with visceral leishmaniasis in an immunocompetent adult-case report and review of the literature. |
| PubMedID- 25970110 | hemophagocytic lymphohistiocytosis in children with visceral leishmaniasis. |
Page: 1